Entyvio (Vedolizumab) Long Term Safety Study

NCT02674308 · clinicaltrials.gov ↗

COMPLETED

Status

5302

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis and Crohn's Disease

Interventions

DRUG: Vedolizumab
OTHER: Other Biologic Agents

Sponsor

Takeda